Immunotherapy company Argos Therapeutics has developed a new technology that could set it apart from other biotechnology cancer treatments — an approach that’s completely personalized to the patient ...

Lummy HK Obtains Rights to Manufacture, Develop and Commercialize AGS-003 in China, Hong Kong, Taiwan, and Macau DURHAM, N.C., April 14, 2015 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq:ARGS) ...

DURHAM, N.C. -- Nov 16, 2007 - Argos Therapeutics announced today that it has granted Therakos, Inc., a Johnson & Johnson company, an exclusive license for the research and development of novel ...

Therakos will use it to enhance treatments against immune-mediated diseases. Argos Therapeutics signed an exclusive licensing agreement with Therakos, a Johnson & Johnson company, for the research and ...

M&A is a massive part of today’s retail landscape; and in the UK this hasn’t got much bigger than Sainsbury’s 2016 takeover of Argos’ parent company Home Retail Group. RetailTechNews caught up with ...

Lendovative, an innovative entrepreneurial group, bringing years of FinTech experience to the table, now offers AR Surveillance™ to mitigate third-party commercial risk Argos Risk, a leading provider ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Argos Therapeutics, Inc. has announced that it is partnering with Adaptive Biotechnologies Corporation to study precise response patterns to Argos' investigational immunotherapies. Under the agreement ...

BOSTON, MA, UNITED STATES, February 11, 2025 /EINPresswire.com/ -- Phrase, a world leader in AI-led translation technology, and Argos Multilingual, a leading provider ...